WILSON KAREN J enters LAVA THERAPEUTICS NV with 10K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/2/2025ACC: 0001415889-25-000023
10K
Baseline shares
100% direct
10K
Direct ownership
1 position
97.65K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned10K
Total
10K direct10K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 10K | Direct |
| Total | 10K | 10K direct |
Derivative Holdings4
Share Options (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
24.26K
Shares owned
N/A
Exercise price
15
Expiration
—
Exercise window
—
Share Options (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
20K
Shares owned
N/A
Exercise price
5.10
Expiration
—
Exercise window
—
Share Options (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
20K
Shares owned
N/A
Exercise price
3.64
Expiration
—
Exercise window
—
Share Options (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
33.39K
Shares owned
N/A
Exercise price
1.59
Expiration
—
Exercise window
—
Total
Underlying
97.65K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Options (Right to Buy) Direct | Common Shares | 15 | — | — | 24.26K | N/A |
| Share Options (Right to Buy) Direct | Common Shares | 5.10 | — | — | 20K | N/A |
| Share Options (Right to Buy) Direct | Common Shares | 3.64 | — | — | 20K | N/A |
| Share Options (Right to Buy) Direct | Common Shares | 1.59 | — | — | 33.39K | N/A |
| Total | 97.65K | 0.00 | ||||